Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DEFIANCE - ClotTriever® Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis

NCT05701917 is registered in ClinicalTrials.gov with Inari Medical as lead sponsor.

NCT NCT05701917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05701917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DEFIANCE - ClotTriever® Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis
Lead sponsor
Inari Medical
Phase
Not applicable
Overall status
Recruiting
Start date
January 6, 2023
Completion date
July 31, 2028
Enrollment
300 (estimated)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

deep venous thrombosis, post-thrombotic syndrome, venous thromboembolism